Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6693399 | 0.95 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL722885 | 0.93 | CYP1A2 (0.38) | CYP1A2 | |
| SCHEMBL6689800 | 0.93 | CYP1A2 (0.38) | CYP1A2 | |
| SCHEMBL6690885 | 0.90 | — | — | |
| SCHEMBL3891175 | 0.82 | — | — | |
| SCHEMBL32671239 | 0.82 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL7644383 | 0.81 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL7940571 | 0.80 | — | — | |
| SCHEMBL23611423 | 0.79 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL6690083 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2004523599-A | — | — | 2004-08-05 | — | — | JP | claimed |
| EP-1353961-A2 | (CYCLOALKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2003-10-22 | — | — | EP | claimed |
| US-6469112-B2 | SOLID TITANIUM CATALYST COMPONENT; AN ORGANOALUMINUM COMPOUND; AND AN ORGANOSILICON COMPOUND COMPRISING AT LEAST ONE (CYCLOALKYL)METHYL GROUP; MAKING HIGH XYLENE SOLUBLE POLYOLEFINS WITH CATALYTIC EFFICIENCY | ENGELHARD CORPORATION | 2002-10-22 | — | — | US | claimed |
| US-20020028893-A1 | (Cycloalkyl) methyl silanes as external donors for polyolefin catalysts | W. R. GRACE & CO.-CONN. | 2002-03-07 | — | — | US | claimed |
| WO-2002016444-A2 | (CYCLOAKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2002-02-28 | — | — | WO | claimed |
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-12 | — | — | US | disclosed |
| EP-4692941-A2 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | Shin-Etsu Chemical Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-1353961-A2 | (CYCLOALKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2003-10-22 | — | — | EP | disclosed |
| US-6469112-B2 | SOLID TITANIUM CATALYST COMPONENT; AN ORGANOALUMINUM COMPOUND; AND AN ORGANOSILICON COMPOUND COMPRISING AT LEAST ONE (CYCLOALKYL)METHYL GROUP; MAKING HIGH XYLENE SOLUBLE POLYOLEFINS WITH CATALYTIC EFFICIENCY | ENGELHARD CORPORATION | 2002-10-22 | — | — | US | disclosed |
| US-20020028893-A1 | (Cycloalkyl) methyl silanes as external donors for polyolefin catalysts | W. R. GRACE & CO.-CONN. | 2002-03-07 | — | — | US | disclosed |
| WO-2002016444-A2 | (CYCLOAKYL)METHYL SILANES AS EXTERNAL DONORS FOR POLYOLEFIN CATALYSTS | ENGELHARD CORPORATION (US) | 2002-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260044081-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS | SMC1A, SPOUT1, LBR | CYP1A2 1818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.